¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty acid binding protein"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • essential amino acid
    Çʼö¾Æ¹Ì³ë»ê
  • ethylenediamine tetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • fixed acid
    °íÁ¤»ê
  • folic acid
    ¿±»ê, Æú»ê
  • folinic acid
    Æú¸®´Ñ»ê
  • formic acid
    Æ÷¸§»ê, °³¹Ì»ê
  • free acid
    À¯¸®»ê
  • fumaric acid
    Ǫ¸¶¸£»ê
  • gastric acid
    ˤȐ
  • general acid
    ÀϹݻê
  • glacial acetic acid
    ºùÃÊ»ê
  • gluconic acid
    ±Û·çÄÜ»ê
  • glucuronic acid
    ±Û·çÄí·Ð»ê
  • glutamic acid
    ±Û·çŽ»ê
  • gamma-aminobutyric acid
    °¨¸¶¾Æ¹Ì³ëºÎƼ¸£»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • lichenic acid
    ÁöÀÇ»ê
  • linoleic acid
    ¸®³î·¹»ê
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
  • malonic acid
    ¸»·Ð»ê
  • mixed acid
    È¥ÇÕ»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • neuraminic acid
    ´º¶ó¹Î»ê
  • neurostearic acid
    ½Å°æÁö¹æ»ê
  • nicotinic acid
    ´ÏÄÚÆ¾»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • acid hematin method
    »êÇ츶ƾ¹ý(¡­Ûö).
  • acid intoxication
    »êÁßµ¶(Áõ)(ß«ñéÔ¸ñø).
  • acid lipase deficiency
    »ê¼º ¸®ÆÄÁ¦ °áÇÌÁõ(ß«àõ¡­ÌÀù¹ñø)
  • acid mucopolysaccharide(s)
    »ê¼ºÁ¡´Ù´çÁú(ïÄÒýÓØòõ)
  • acid perfusion
    »ê°ü·ù(߫δêü), »êȯ·ù.
  • acid phosphatase
    »ê¼ºÆ÷½ºÆÄŸÁ¦
  • acid phosphatase
    »ê¼ºÆ÷½ºÆÄÅ×À̽ºÁ¦.
  • acid phosphatase
    »ê¼º Æ÷½ºÆÄÅ×À̽º(ß«àõ¡­)
  • acid phosphatase
    »ê¼ºÀλêÈ¿¼î
  • acid phosphatase assay
    »ê¼ºÆ÷½ºÆÄŸÁ¦ ÃøÁ¤
  • acid pyuria
    »ê¼º ³ó´¢
  • acid radical
    »ê±â(ß«Ðñ).
  • acid salt
    »ê¼º¿°(ß«àõç¤).
  • acid springs
    »ê¼ºÃµ(Ë×ËÛ̧).
  • acid sterile pyuria
    »ê¼º¹«±Õ³ó´¢
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • monocyte chemotactant protein 1(mcp-1)
    ´Ü±¸È­ÇÐÁÖ¼º´Ü¹é(¡­ûùùÊñ«àõÓ±ÛÜ) 1 (MCP-1)
  • muscle protein
    ±Ù´Ü¹é(ÐÉÓ±ÛÜ).
  • myelin basic protein
    ¼öÃÊ(âÐÃÊ)¿°±â¼º ´Ü¹é
  • myelin basic protein
    ¸¶ÀÌ¿¤¸° ¿°±â´Ü¹éÁú
  • myelin basic protein antigen
    ¼öÃʱâÃʴܹé(âËôþÐñõ¨Ó±ÛÜ)Ç׿ø(ù÷ê«)
  • myeloma protein
    °ñ¼öÁ¾´Ü¹éÁú
  • myotonin-protein kinase
    ¹Ì¿ÀÅä´Ñ-´Ü¹é(Ó±ÛÜ) Ű³ªÁ¦
  • non-protein nitrogenous compound
    ºñ´Ü¹é(Áú)Áú¼ÒÈ­ÇÕ¹°
  • nonspecific protein therapy
    ºñƯÀ̼º ´Ü¹é¿ä¹ý.
  • nonstructural protein
    ºñ±¸Á¶ ´Ü¹é
  • nuclear protein antigen
    Çٴܹé(Áú)Ç׿ø
  • oligomeric protein
    ¿Ã¸®°í¸Ó´Ü¹éÁú.
  • original endotoxin protein
    ±Õ³»µ¶¼Ò´Ü¹éÁú.
  • outer membrane protein
    ¿Ü¸·´Ü¹éÁú
  • p69 protein
    p69´Ü¹é(¡­Ó±ÛÜ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • link protein
    ¿¬°á´Ü¹éÁú(֧̿ӱÛÜòõ)
  • lipid-globular protein mosaic model
    "ÁöÁú-±¸»ó´Ü¹éÁú(ò·òõϹßÒÓ±ÛÜòõ) , ¸ðÀÚÀÌÅ©¸ðµ¨"
  • liquid protein diet
    ¾×ü´Ü¹éÁú½Ä(äûô÷Ó±ÛÜòõãÝ)
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • low-quality protein
    ÀúÁú´Ü¹éÁú(î¸òõÓ±ÛÜòõ)
  • matrix protein
    ±âÁú´Ü¹éÁú(ѨòõÓ±ÛÜòõ)
  • maturation protein
    ¼º¼÷´Ü¹éÁú(à÷âÙÓ±ÛÜòõ)
  • melting protein
    À¶ÇشܹéÁú(ë×ú°Ó±ÛÜòõ)
  • minimum protein requirement
    ÃּҴܹéÁú¿ä±¸·®(õÌá³Ó±ÛÜòõé©Ï´Õá)
  • moderator protein
    Á¶Á¤ÀڴܹéÁú(ðàïÚí­Ó±ÛÜòõ)
  • modulator protein
    Á¤Á¶´Ü¹éÁú(ïÚðàÓ±ÛÜòõ)
  • Mo-Fe protein
    Mo-Fe ´Ü¹éÁú(Ó±ÛÜòõ)
  • molybdoiron protein
    ¸ô¸®ºêµµÃ¶(ôÑ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • M-protein
    M ´Ü¹éÁú(Ó±ÛÜòõ)
  • multifunctional protein
    ´Ù±â´É´Ü¹éÁú(ÒýÐüÒöÓ±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
CBG capillary blood gases; coronary bypass graft; corticosteroid-binding globulin; cortisol-binding glob...
IBC Institutional Biosafety Committee; iodine-binding capacity; iron-binding capacity; isobutyl cyanoacr...
TBI thyroid-binding index; thyroxine-binding index; tooth-brushing instruction; total-body irradiation; ...
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CRP chronic relapsing pancreatitis; corneal-retinal potential; coronary rehabilitation program; C-reacti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
OLETF Otsuka Long Evans Tokushima Fatty
SCFA Short Chain Fatty Acids
TFA Trans fatty acids
VFA Volatile Fatty Acids
ZDF Zucker Diabetic Fatty
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lymphocantric acid
    ¸²Æ÷Ä­Æ®¸£»ê
    Àӯļº ¹éÇ÷º´ ȯÀÚÀÇ ¿ä¿¡¼­ ÃßÃâµÈ´Ù.
  • lysalbinic acid
    ¸®»ìºó »ê
    ³­¹éÀ» °¡¼º ¼Ò¿À´Ù·Î ó¸®ÇÔÀ¸·Î½á ¾ò¾îÁö´Â »ê.
  • lysergic acid
    ¸®À縣±×»ê
    ¸Æ°¢ ¾ËÄ®·ÎÀ̵åÀÇ ¸ðü·Î, ±× À̼ºÃ¼ÀÎ ÀÌ¼Ò ¸®Á¦¸£±×»ê°ú ÇÔ²² Æ®¸®ÆéƼµå ¶Ç´Â ¾Æ¹Ì³ë ÇÁ·ÎÆÄ³î°ú °áÇÕÇÏ¿© ¸Æ°¢ ¾ËÄ®·ÎÀ̵å·ù¸¦ Çü¼ºÇÑ´Ù.
  • lyxonic acid
    ¸¯¼Õ»ê
  • maleic acid
    ¸»·¹»ê, ¸»·¹Àλê
    ºÒÆ÷È­ ÀÌ¿°±â»ê.
  • malic acid
    ´É±Ý»ê
    µ¿ÀǾî=hydroxysuccinic acid. Æ®¶óÀÌÄ«¸£º¹½Ç»ê ȸ·ÎÀÇ Áß°£ ¹°Áú. ´ú ÀÍ°í ½Å »ç°ú¿Í ´Ù¸¥ ¸¹Àº °ú½Ç ¼Ó¿¡ µé¾îÀÖ´Ù. ±«Ç÷º´ÀÇ Ä¡·á¿¡ »ç¿ëµÇ±âµµ ÇÑ´Ù.
  • malonic acid
    ¸»·Ð»ê
    °áÁ¤¼ºÀÇ ÀÌ¿°±â»ê.
  • meclofenamic acid
    ¸ÞŬ·ÎÆä³ª¹Ìµå»ê
    °ñ°üÀý¿° ¹× ·ù¸¶ÅäÀÌµå °üÀý¿°ÀÇ Ä¡·á¿¡ meclofenamate sodiumÀ¸·Î »ç¿ëµÈ´Ù.
  • meconic acid
    ¸ÞÄÜ»ê
    ¹é»ö °áÁ¤¼º »ê.
  • mefenamic acid
    ¸ÞÆä³²»ê
    °áÁ¤¼º ºÐ¸», ÇÔ¿°ÁõÁ¦.
  • messenger ribonucleic acid
    Àü·É RNA
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metaphosphoric acid
    ¸ÞŸÀλê
    ÀλêÀÇ Çϳª. Çü»óÀ¸·Î º¸¾Æ À¯¸®»ó ÀÎ»ê ¶Ç´Â ºù»ó ÀλêÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ½Ä HPO. ¹Ì»ý¹°, °ïÃæ·ù ¶Ç´Â ¾î¶² Á¾·ùÀÇ µ¿¹°ÀÇ Á¶Á÷ µî¿¡ Á¸ÀçÇÑ´Ù. ¹«»ö Åõ¸íÇÑ À¯¸®»ó °íü ¶Ç´Â ºÎµå·¯¿î ºñ´Ü½Ç ¸ð¾çÀÇ ±«»ó ¹°Áú·Î, ºÐÀÚ·® 79.98, ºñÁß 2.2ÀÌ´Ù. Á¶ÇؼºÀ̸ç, ½ÀÇÑ °ø±â ¼Ó¿¡ ¹æÄ¡ÇÏ¸é ¿À¸£Åä Àλê HPO°¡ µÈ´Ù. ¹°, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. °¡¿­ÇÏ¸é ¿ëÀ¶ÇÏ¿© Á¡¼ºµµ°¡ Áõ°¡ÇÏ°í ´õ¿í °¡¿­ÇÏ¸é ½ÂÈ­ÇÑ´Ù. ¼ö¿ë¾× ¼Ó¿¡¼­´Â ÁßÇÕü¸¦ Àß ¸¸µé°í, °£´ÜÇÑ °Íµµ »ïÇÕü³ª »çÇÕü°¡ µÇÁö¸¸, Àå½Ã°£ ¹æÄ¡ÇÏ¸é ¿À¸£ÅäÀλêÀ¸·Î º¯ÇÑ´Ù. ¸ÞŸÀÎ»ê ¿ë¾×¿¡ Áú»ê Àº ¿ë¾×À» °¡ÇÏ¸é ¹é»ö ħÀüÀÌ »ý±ä´Ù. ¸ÞŸÀλêÀº ¿À¸£ÅäÀÎ»ê ¶Ç´Â ÇÇ·ÎÀλê HPOÀ» 300 ¡É ÀÌ»óÀ¸·Î °¡¿­ÇÏ¸é »ý±ä´Ù. 2HPO 2j HPO+HO HPO 2j 2HPO+HO ¶Ç ¿À»êÈ­ÀÎÀ» 0 ¡É ÀÌÇÏ·Î ¼öÈ­ÇØµµ ¾ò´Â´Ù. Ä¡°ú¿ë ½Ã¸àÆ® , È­Çкм®¿ë ½Ã¾à, º¸ÀÏ·¯ ûÁ¤Á¦, ÀμâÁ¦ÆÇ, °¡Á×ÀÇ ¹«µÎÁú µî¿¡ ¾²À̸ç, Ä®·ý¿°Àº À¯Á¦Ç°ÀÇ Á¡¼ºµµ Áõ°¡Á¦, ¼¼Á¦, ÇÜ, ¼Ò½ÃÁöÀÇ Ã·°¡Á¦·Î »ç¿ëµÈ´Ù. ¶ÇÇÑ, ¸ÞŸÀλêÀº »ý¹°ÇлóÀ¸·Îµµ ¸Å¿ì Èï¹Ì·Î¿î ¼ºÁúÀ» °¡Áö°í Àִµ¥, È¿¸ð¿¡¼­´Â ÇÙ»êÀÇ ÇÕ¼º¿¡ ÇÊ¿äÇÑ Àΰú ¿¡³ÊÁö¸¦ ¸ÞŸÀλêÀÌ °ø±ÞÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • methacrylic acid
    ¸ÞŸ ¾ÆÅ©¸¯ »ê
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
calcium dependent regulator protein <protein> (CDRP) Early name for calmodulin.
(18 Nov 1997)
calmodulin-dependent protein kinase IV kinase <enzyme> Phosphorylates and activates cam-kinase iv; from brain
Registry number: EC 2.7.10.-
Synonym: cam-kinase iv kinase
(26 Jun 1999)
cAMP receptor protein catabolite (gene) activator protein
p150 protein kinase <enzyme> Mw 150 kD; forms a cellular complex with phosphatidylinositol 3-kinase; a homolog of vps15 protein kinase; amino acid sequence given in first source
Registry number: EC 2.7.1.-
(26 Jun 1999)
p21(ras) farnesyl-protein transferase <enzyme> Transfers the farnesyl moiety from farnesyl pyrophosphate to a cysteine in p21(ras) proteins; composed of an alpha and a beta subunit
Registry number: EC 2.5.1.-
Synonym: farnesyl-protein transferase p21(ras), ras p21 farnesyl-protein transferase, protein-cysteine farnesyltransferase, pc farnesyltransferase, protein farnesyltransferase, p21(ras) farnesyltransferase, farnesyl-protein transferase-alpha, farnesyl-protein transferase-beta, ft alpha, ft beta, caax farnesyltransferase, ftase enzyme
(26 Jun 1999)
P400 protein <protein> Inositol 1,4, 5 triphosphate receptor (InsP3 R). Key protein to understanding mechanisms of InsP3 mediated Ca mobilisation. Originally found as a cerebellar glycoprotein of 250 kD and subsequently shown to be identical to the InsP3 receptor protein.
(18 Nov 1997)
p54 protein kinase <enzyme> A stress-activated kinase related to erk-1 and erk-2 but activated preferentially by heat shock, protein-synthesis inhibitors and thf-alpha; phosphorylates c-jun proteins; genbank l27111
Registry number: EC 2.7.10.-
Synonym: p54 map kinase
(26 Jun 1999)
gag protein <molecular biology> The protein of the nucleocapsid shell around the RNA of a retrovirus.
(18 Nov 1997)
macrophage inflammatory protein <cytokine> A chemokine that is chemotactic for neutrophils and monocytes, stimulates macrophages, and may play a role in regulating haematopoiesis. Its two variants, mip-1alpha and mip-1beta, are 60% homologous to each other.
They are heparin-binding proteins that exhibit a number of inflammatory and immunoregulatory activities. Originally identified as secretory products of macrophages, these chemokines are produced by a variety of cell types including neutrophils, fibroblasts, and epithelial cells.
They most likely also play a significant role in respiratory tract defenses.
(20 Sep 2002)
Varciella-Zoster ORF47-associated protein kinase <enzyme> Catalyses the in vitro phosphorylation of the vzv orf62 protein
Registry number: EC 2.7.1.-
Synonym: vzv orf47-apk
(26 Jun 1999)
MAG protein <protein> Myelin associated glycoprotein, one of the immunoglobulin superfamily.
(18 Nov 1997)
palmitoyl-protein thioesterase <enzyme> Cleaves palmitoyl-cysteine bond of proteins; genbank u44772; do not confuse with palmitoyl-acyl carrier protein thioesterase
Registry number: EC 3.1.2.-
Synonym: palmitoyl-ras thioesterase, protein palmitoyl thioesterase
(26 Jun 1999)
major intrinsic protein <protein> Family of structurally related proteins with 6 transmembrane segments, associated with gap junctions or vacuoles. MIP is found in lens fibre gap junctions. Other members: nodulin 26 (soybean), tonoplast intrinsic protein (TIP) found in plant storage vacuoles, Drosophila neurogenic protein big brain.
(18 Nov 1997)
gap-43 protein A nervous tissue specific protein which is highly expressed in neurons during development and nerve regeneration. It has been implicated in neurite outgrowth, long-term potentiation, signal transduction, and neurotransmitter release. It is also a substrate of protein kinase c.
(12 Dec 1998)
GAP protein <molecular biology> Originally purified as a 125 kD protein from bovine brain (1044 amino acids), stimulates the GTPase activity of ras p21 and thereby switches it to the inactive state.
GAP may itself be regulated by phospholipids and by phosphorylation on a tyrosine residue by growth factor receptors (PDGF R, EGF R). The neurofibromatosis type 1 gene NF1) codes for a protein homologous to GAP. GAP has both SH2 and SH3 domains. Another example is sar 1 (from yeast).
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á